Free Trial

Sorrento Therapeutics (SRNE) Competitors

$0.01
0.00 (0.00%)
(As of 05/28/2024 ET)

SRNE vs. SCNI, CELZ, NSTGQ, TTNP, FRTX, PALI, KRBP, ONVO, TCON, and GENE

Should you be buying Sorrento Therapeutics stock or one of its competitors? The main competitors of Sorrento Therapeutics include Scinai Immunotherapeutics (SCNI), Creative Medical Technology (CELZ), NanoString Technologies (NSTGQ), Titan Pharmaceuticals (TTNP), Fresh Tracks Therapeutics (FRTX), Palisade Bio (PALI), Kiromic BioPharma (KRBP), Organovo (ONVO), TRACON Pharmaceuticals (TCON), and Genetic Technologies (GENE). These companies are all part of the "biological products, except diagnostic" industry.

Sorrento Therapeutics vs.

Scinai Immunotherapeutics (NASDAQ:SCNI) and Sorrento Therapeutics (NASDAQ:SRNE) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, community ranking, risk, profitability, valuation and earnings.

Scinai Immunotherapeutics has a beta of 2.45, meaning that its share price is 145% more volatile than the S&P 500. Comparatively, Sorrento Therapeutics has a beta of 1.93, meaning that its share price is 93% more volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Scinai Immunotherapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Sorrento Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Scinai Immunotherapeutics had 2 more articles in the media than Sorrento Therapeutics. MarketBeat recorded 4 mentions for Scinai Immunotherapeutics and 2 mentions for Sorrento Therapeutics. Sorrento Therapeutics' average media sentiment score of 1.25 beat Scinai Immunotherapeutics' score of 0.00 indicating that Scinai Immunotherapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Scinai Immunotherapeutics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sorrento Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Scinai Immunotherapeutics has higher earnings, but lower revenue than Sorrento Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scinai ImmunotherapeuticsN/AN/A-$6.50M-$32.70-0.11
Sorrento Therapeutics$62.84M0.09-$572.84MN/AN/A

58.4% of Scinai Immunotherapeutics shares are held by institutional investors. Comparatively, 0.0% of Sorrento Therapeutics shares are held by institutional investors. 6.0% of Scinai Immunotherapeutics shares are held by insiders. Comparatively, 2.6% of Sorrento Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Scinai ImmunotherapeuticsN/A N/A -64.18%
Sorrento Therapeutics N/A N/A N/A

Sorrento Therapeutics received 610 more outperform votes than Scinai Immunotherapeutics when rated by MarketBeat users.

CompanyUnderperformOutperform
Scinai ImmunotherapeuticsN/AN/A
Sorrento TherapeuticsOutperform Votes
610
70.85%
Underperform Votes
251
29.15%

Summary

Scinai Immunotherapeutics beats Sorrento Therapeutics on 6 of the 9 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRNE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SRNE vs. The Competition

MetricSorrento TherapeuticsBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$5.51M$2.85B$4.93B$8.06B
Dividend YieldN/A2.24%2.80%3.96%
P/E RatioN/A13.00136.8415.80
Price / Sales0.09310.042,496.6172.33
Price / CashN/A162.8532.7128.77
Price / Book-0.204.104.934.37
Net Income-$572.84M-$45.89M$103.91M$213.15M
7 Day PerformanceN/A-3.40%-1.31%-1.10%
1 Month PerformanceN/A4.45%3.14%3.07%
1 Year PerformanceN/A2.65%4.89%7.17%

Sorrento Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SCNI
Scinai Immunotherapeutics
0 of 5 stars
$3.79
-5.5%
N/AN/A$7.09MN/A-1.1633Stock Split
Short Interest ↓
Gap Up
CELZ
Creative Medical Technology
1.3632 of 5 stars
$4.40
+2.3%
N/A-23.1%$5.94M$10,000.00-1.184Short Interest ↓
Positive News
Gap Down
NSTGQ
NanoString Technologies
0 of 5 stars
$0.12
-7.6%
N/AN/A$5.85M$127.26M-0.03550Gap Up
TTNP
Titan Pharmaceuticals
0 of 5 stars
$6.35
-1.6%
N/A-57.2%$5.78M$180,000.000.004Analyst Forecast
Short Interest ↓
Positive News
Gap Down
FRTX
Fresh Tracks Therapeutics
0 of 5 stars
$0.92
flat
N/A+50.1%$5.49M$8.01M-0.654
PALI
Palisade Bio
2.8071 of 5 stars
$5.41
-7.5%
$22.50
+315.9%
-75.8%$5.08M$250,000.00-0.239Short Interest ↓
Gap Down
KRBP
Kiromic BioPharma
0 of 5 stars
$3.23
+4.2%
N/A-14.9%$4.97MN/A-0.3335Gap Up
ONVO
Organovo
0.8023 of 5 stars
$1.03
-4.6%
N/A-48.1%$10.34M$370,000.00-0.4718Analyst Forecast
Short Interest ↓
News Coverage
TCON
TRACON Pharmaceuticals
2.6127 of 5 stars
$1.49
+3.5%
$60.00
+3,926.8%
-87.3%$3.99M$12.05M2.2217Short Interest ↓
News Coverage
Gap Up
GENE
Genetic Technologies
0 of 5 stars
$2.36
+3.5%
N/A-55.6%$10.41M$5.85M0.0060Short Interest ↓
News Coverage
Gap Up

Related Companies and Tools

This page (NASDAQ:SRNE) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners